HPV Tests Should Include Non-Vaccine Genotypes, U.S. Guidance Says

International Medical Device Regulatory Monitor
A A
Companies developing diagnostics for human papillomavirus (HPV) should be alert for the impact of HPV vaccines on the potential test subject population, the U.S. Food and Drug Administration (FDA) says.

To View This Article:

Login

Subscribe To International Medical Device Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00